Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ginkgolides Meglumine Injection in Ischemic Stroke
NCT01958957Phase 4Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jun 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jun 2013; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01958957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01958957.